🔎 Trials Near Me

Utama › Penyakit Paru Interstisial › Utah

Kajian klinikal Penyakit Paru Interstisial di Utah

9 kajian untuk Penyakit Paru Interstisial sedang mencari peserta di lokasi di Utah.

Bandar di Utah

Teks kajian rasmi (Bahasa Inggeris)

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

  • University of Utah Health Sciences Center, Salt Lake City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07540988

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • USA025, Salt Lake City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07179380

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

  • GSK Investigational Site, Salt Lake City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06572384

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  • University of Utah, Salt Lake City
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06968845

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • University of Utah, Salt Lake City
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06911632

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Intermountain Medical Center, Murray
  • University of Utah Health, Salt Lake City
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT06388421

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • University of Utah, Salt Lake City
Mengambil pesertaKajian pemerhatian
Umur 21 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT01915511

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • Intermountain Medical Center, Murray
  • University of Utah Health, Salt Lake City
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT05943535

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

  • aTyr Investigative Site, Salt Lake City
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Mei 2025 · NCT05892614

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.